Form SCHEDULE 13G/A UPEXI, INC. Filed by: Hivemind Capital Partners, LLC
http://archive.fast-edgar.com/20260814/AD2YR22CZW2RMJSZ2K2A2ZY24ANRZZ22Z282
Filed on: August 14, 2026
Form SCHEDULE 13G UPEXI, INC. Filed by: Hivemind Capital Partners, LLC
html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td
{
margin: 0;
padding: 0;
border: 0;
outline: 0;
font-weight: inherit;
font-style: inherit;
font-size: 100%;
font-family: inherit;
vertical-align:... (continue reading...)
Form 4 Ondas Inc. For: Jul 01 Filed by: Seidl Randy
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 Warner Bros. Discovery, For: Aug 13 Filed by: Zaslav David
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 Natera, Inc. For: Aug 10 Filed by: Sheena Jonathan
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
More SEC Filings
View Older Stories-
Form SCHEDULE 13G NextCure, Inc. Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G Yarrow Bioscience, Inc. Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13D/A Better Home & Finance Filed by: Activant Ventures Advisors III, LLC
-
Form SCHEDULE 13G Rein Therapeutics, Inc. Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G/A General Fusion Group Filed by: MERUS GLOBAL INVESTMENTS, LLC
-
Form SCHEDULE 13G Research Alliance Corp Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G PLIANT THERAPEUTICS, Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G JATT II Acquisition Corp Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G Editas Medicine, Inc. Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G Cyclerion Therapeutics, Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G Boundless Bio, Inc. Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G Amanat Acquisition Corp. Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G Banzai International, Filed by: CP BF Lending, LLC
-
Form SCHEDULE 13G/A CNS Pharmaceuticals, Filed by: Ikarian Capital, LLC
-
Form 4 Q2 Holdings, Inc. For: Aug 13 Filed by: Price Jonathan
-
Form SCHEDULE 13G/A Connect Biopharma Holdin Filed by: Ikarian Capital, LLC
-
Form SCHEDULE 13G Quince Therapeutics, Filed by: Ikarian Capital, LLC
-
Form 144 Outset Medical, Inc. Filed by: Trigg Leslie
-
Form 144 Outset Medical, Inc. Filed by: Brottem John L.
-
Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: Ikarian Capital, LLC
-
Form 144 Outset Medical, Inc. Filed by: Gaeta Renee
-
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Ikarian Capital, LLC
-
Form SCHEDULE 13G InMed Pharmaceuticals Filed by: Ikarian Capital, LLC
-
Form SCHEDULE 13G/A Galera Therapeutics, Filed by: Ikarian Capital, LLC
-
Form 4 NEOGEN CORP For: Aug 14 Filed by: Moylan John Patrick
-
Form SCHEDULE 13G/A KAZIA THERAPEUTICS LTD Filed by: Ikarian Capital, LLC
-
Form 4 NEOGEN CORP For: Aug 14 Filed by: Ranalli Tamara A.
-
Form 4 NETLIST INC For: Aug 12 Filed by: SASAKI GAIL M
-
Form SCHEDULE 13G Yesway, Inc. Filed by: TRKLA THOMAS N.
-
Form SCHEDULE 13G/A EverCommerce Inc. Filed by: Remer Eric Richard
-
Form 4 NEOGEN CORP For: Aug 14 Filed by: Stacey Jennifer Evans
-
Form SCHEDULE 13G/A NextCure, Inc. Filed by: Ikarian Capital, LLC
-
Form 4 Outlook Therapeutics, For: Aug 14 Filed by: Jahr Robert Charles
-
Form 4 Lifeway Foods, Inc. For: Aug 12 Filed by: SMOLYANSKY EDWARD
-
Form 4 NEOGEN CORP For: Aug 14 Filed by: Riggsbee Richard Bryan
-
Form SCHEDULE 13G/A Pharvaris N.V. Filed by: GENERAL ATLANTIC, L.P.
-
Form 4 NEOGEN CORP For: Aug 14 Filed by: Nassif Mikheal
-
Form 4 Cue Biopharma, Inc. For: Aug 12 Filed by: Lin Shao-Lee
-
Form 144 Cue Biopharma, Inc. Filed by: Lin Shao-Lee
-
Form 4 CLEANSPARK, INC. For: Aug 13 Filed by: Monnig Taylor
-
Form 144 Kinetik Holdings Inc. Filed by: ISQ Global Fund II GP LLC
-
Form 144 CLEANSPARK, INC. Filed by: Monnig Taylor
-
Form 4 CLEANSPARK, INC. For: Aug 13 Filed by: Garrison Scott Eugene
-
Form 144 CLEANSPARK, INC. Filed by: Garrison Scott Eugene
-
Form 4 CLEANSPARK, INC. For: Aug 13 Filed by: Vecchiarelli Gary Anthony
-
Form SCHEDULE 13G/A Smart Share Global Ltd Filed by: Silver Point Capital L.P.
-
Form 144 CLEANSPARK, INC. Filed by: Vecchiarelli Gary Anthony
-
Form 4 CLEANSPARK, INC. For: Aug 13 Filed by: Schultz S. Matthew
-
Form SCHEDULE 13G Braemar Hotels & Resorts Filed by: ZAZOVE ASSOCIATES LLC
-
Form 144 CLEANSPARK, INC. Filed by: Schultz S. Matthew
